MMIRF
Price
$0.02
Change
-$0.05 (-71.43%)
Updated
Apr 9 closing price
Capitalization
47.26M
OTLC
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Apr 11 closing price
Capitalization
21M
37 days until earnings call
Ad is loading...

MMIRF vs OTLC

Header iconMMIRF vs OTLC Comparison
Open Charts MMIRF vs OTLCBanner chart's image
Medmira
Price$0.02
Change-$0.05 (-71.43%)
Volume$1K
Capitalization47.26M
Oncotelic Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$401.06K
Capitalization21M
MMIRF vs OTLC Comparison Chart
Loading...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MMIRF vs. OTLC commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMIRF is a Hold and OTLC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (MMIRF: $0.02 vs. OTLC: $0.05)
Brand notoriety: MMIRF and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MMIRF: 16% vs. OTLC: 279%
Market capitalization -- MMIRF: $47.26M vs. OTLC: $21M
MMIRF [@Biotechnology] is valued at $47.26M. OTLC’s [@Biotechnology] market capitalization is $21M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MMIRF’s FA Score shows that 1 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • MMIRF’s FA Score: 1 green, 4 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, MMIRF is a better buy in the long-term than OTLC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OTLC’s TA Score shows that 3 TA indicator(s) are bullish.

  • OTLC’s TA Score: 3 bullish, 5 bearish.

Price Growth

MMIRF (@Biotechnology) experienced а -72.29% price change this week, while OTLC (@Biotechnology) price change was -12.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

OTLC is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MMIRF($47.3M) has a higher market cap than OTLC($21M). MMIRF YTD gains are higher at: 58.015 vs. OTLC (47.286). MMIRF has higher annual earnings (EBITDA): -2.57M vs. OTLC (-4.05M). MMIRF has more cash in the bank: 1.06M vs. OTLC (149K). MMIRF has less debt than OTLC: MMIRF (9.54M) vs OTLC (12.9M). MMIRF has higher revenues than OTLC: MMIRF (356K) vs OTLC (0).
MMIRFOTLCMMIRF / OTLC
Capitalization47.3M21M225%
EBITDA-2.57M-4.05M63%
Gain YTD58.01547.286123%
P/E RatioN/AN/A-
Revenue356K0-
Total Cash1.06M149K709%
Total Debt9.54M12.9M74%
FUNDAMENTALS RATINGS
MMIRF vs OTLC: Fundamental Ratings
MMIRF
OTLC
OUTLOOK RATING
1..100
9884
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
59
Fair valued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
3835
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (4) in the null industry is somewhat better than the same rating for OTLC (59). This means that MMIRF’s stock grew somewhat faster than OTLC’s over the last 12 months.

MMIRF's Profit vs Risk Rating (96) in the null industry is in the same range as OTLC (100). This means that MMIRF’s stock grew similarly to OTLC’s over the last 12 months.

OTLC's SMR Rating (94) in the null industry is in the same range as MMIRF (100). This means that OTLC’s stock grew similarly to MMIRF’s over the last 12 months.

OTLC's Price Growth Rating (35) in the null industry is in the same range as MMIRF (38). This means that OTLC’s stock grew similarly to MMIRF’s over the last 12 months.

OTLC's P/E Growth Rating (94) in the null industry is in the same range as MMIRF (100). This means that OTLC’s stock grew similarly to MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OTLC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
ZRX.X0.2359240.006839
+2.99%
0x Protocol cryptocurrency
NTRN.X0.1188100.002551
+2.19%
Neutron cryptocurrency
WNXM.X33.0896870.364544
+1.11%
Wrapped NXM cryptocurrency
FRONT.X0.212166-0.000035
-0.02%
Frontier cryptocurrency
HBAR.X0.167513-0.000030
-0.02%
Hedera cryptocurrency

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
-3.12%
AZTR - MMIRF
24%
Poorly correlated
+4.18%
SRPT - MMIRF
22%
Poorly correlated
+1.43%
SAGE - MMIRF
22%
Poorly correlated
+3.62%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+3.31%
TENX - OTLC
23%
Poorly correlated
+3.93%
MNKD - OTLC
22%
Poorly correlated
+0.43%
IMTX - OTLC
21%
Poorly correlated
+4.28%
MMIRF - OTLC
15%
Poorly correlated
N/A
IUGNF - OTLC
13%
Poorly correlated
-22.00%
More